Volume 8, Issue 3 (September 2016)                   Iranian Journal of Blood and Cancer 2016, 8(3): 80-85 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghasemi A, Abbasian S, Ghaffari K, Salmanpour Z. Prevalence of Alloantibodies and Autoantibodies in Transfusion Dependent Thalassemia Patients. Iranian Journal of Blood and Cancer 2016; 8 (3) :80-85
URL: http://ijbc.ir/article-1-671-en.html
1- , sadegh_abasian@yahoo.com
Abstract:   (5974 Views)

Background: The development of anti-red blood cell alloantibodies remains a major problem in transfusion of blood in thalassemia major patients. Also, Autoantibodies can result in clinical hemolysis and difficulty in cross-matching blood. We studied the frequency of red blood cell alloimmunization and autoimmunization among thalassemia patients who received regular transfusions in Ilam province of Iran. 
Methods: This study was carried out on 110 multiply transfused patients with thalassemia major. The saline method, Albumin method, direct/indirect coombs’ and Three cell panel test used for detection of red blood cell alloantibody/ autoantibody. 
Results: 12 patients out of total 110 patients (10.9 %) developed alloantibodies and 2 (1.81 %) developed autoantibodies. Rh and Kell blood group system alloantibodies were most commonly found, with the majority of patients being transfused with blood matched for ABO and D antigens only. 
Conclusion: This study suggests screening RBC antigens prior to transfusion. Our findings accentuate the necessity of antigen typing of supposed to be transfused red blood cells and screenings tests before the first transfusion, at least for Rh (Rh system) and Kell (Kell system) antigens.

Full-Text [PDF 460 kb]   (3615 Downloads)    
: Original Article | Subject: Adults Hematology & Oncology
Received: 2016/06/21 | Accepted: 2016/09/11 | Published: 2016/10/18

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 All Rights Reserved | Iranian Journal of Blood and Cancer

Designed & Developed by : Yektaweb